Pharmaceutical Antitrust Advisory Board (PAAB)

ACI_PAAB.jpg

PHARMACEUTICAL ANTITRUST CONFERENCE ADVISORY BOARD:

Comprised of a select group of industry leaders, American Conference Institute’s Pharmaceutical Antitrust Advisory Board (PAAB) was created as a part of ACI’s ongoing effort to provide its audience with access to key experts in the field and industry leading content. Developed to provide insight on emerging topics as well as litigation and enforcement trends, the PAAB also provides guidance on the overall direction of the conference program and identification of relevant speakers and industry leaders..

Meet the PAAB:

Melissa S. Barnes
Assistant General Counsel
Eli Lilly and Company
(Indianapolis, IN)
Margaret Ayres
Stephen C. Cipolla
Counsel
Merck & Co., Inc.
(North Wales, PA)
Paul R. Berger
Seth Silber
Partner
Wilson Sonsini Goodrich & Rosati
(Washington, DC)
Nancy Z. Boswell
Jeffrey W. Brennan
Partner
Dechert LLP
(Washington, DC)
Peter Clark
David W. Hull
Partner
Covington & Burling
(Brussels, Belgium)
Timothy L. Dickinson
Jonathan Wasserman
Vice President & Senior Counsel
Litigation & Government Investigations
Bristol-Myers Squibb (Plainsboro, NJ)